Literature DB >> 2655758

Gilbert's syndrome.

K J Watson, J L Gollan.   

Abstract

While Gilbert's syndrome is extremely common and benign, its pathogenesis may not be as straightforward as once believed. It has been used as a model to examine aberrations of virtually every step in bilirubin metabolism. The clinical hallmarks are of a hereditary, chronic, mild unconjugated hyperbilirubinaemia. Not infrequently subclinical haemolysis may coexist. Liver histology is normal although some minor ultrastructural abnormalities may be evident. The universal defect appears to be a reduction in hepatic bilirubin-GT activity. However, other associated abnormalities in bilirubin metabolism, which occur less consistently, suggest that this may not be the sole defect in all patients. The syndrome is almost certainly part of a spectrum which includes the Crigler-Najjar syndromes; molecular biology data suggests that there is an absence of one (or even more) GT isoenzymes in these disorders. Whether one or more genes is consistently culpable remains open to speculation. Despite the complicated pathogenesis of Gilbert's syndrome, management remains simply reassurance alone.

Entities:  

Mesh:

Year:  1989        PMID: 2655758     DOI: 10.1016/0950-3528(89)90004-3

Source DB:  PubMed          Journal:  Baillieres Clin Gastroenterol        ISSN: 0950-3528


  3 in total

1.  ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.

Authors:  Paul Y Kwo; Stanley M Cohen; Joseph K Lim
Journal:  Am J Gastroenterol       Date:  2016-12-20       Impact factor: 10.864

2.  Intermittent jaundice in patients with acute leukaemia: a common mutation of the bilirubin uridine-diphosphate glucuronosyltransferase gene among Asians.

Authors:  T Kimura; K Akaba; T Ikegami; K Akiba; C Kanazawa; M Katsuura; Y Shimizu; M Imaizumi; C Lin; K Hayasaka
Journal:  J Inherit Metab Dis       Date:  1999-08       Impact factor: 4.982

3.  The inverse starving test is not a suitable provocation test for Gilbert's syndrome.

Authors:  Niels Teich; Inken Lehmann; Jonas Rosendahl; Michael Tröltzsch; Joachim Mössner; Ingolf Schiefke
Journal:  BMC Res Notes       Date:  2008-06-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.